Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting session on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC.
The Expert Group meeting on the management of EGFR mutation-positive non-small cell lung cancer (NSCLC) convenes to address critical aspects of treatment strategies, therapeutic advancements, and patient care. Participants, including leading oncologists, researchers, and healthcare professionals, gather to discuss the latest developments in targeted therapies, molecular diagnostics, and personalized medicine for patients with EGFR mutation-positive NSCLC.
The meeting aims to foster collaboration, exchange scientific insights, and explore innovative approaches to optimize patient outcomes and quality of life. Through comprehensive discussions, evidence-based presentations, and case studies, the Expert Group endeavors to refine treatment algorithms, identify emerging challenges, and propose novel solutions to enhance the standard of care for individuals affected by EGFR mutation-positive NSCLC.
Ultimately, the collaborative efforts of the Expert Group contribute to advancing the field of oncology and improving the prognosis and management of EGFR-driven NSCLC.
Therefore, get an overall knowledge on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Woman Loses 6-Year Battle With Mouth Tumor
2.
SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims
3.
A video animation guide to assist young people who are fatigued from cancer.
4.
FDA Expands Approval of Osimertinib in Lung Cancer
5.
Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'
1.
Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources
2.
Precision Oncology Advances: Neoantigen Therapies, TCR Strategies & Radiotherapy Innovations
3.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
4.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
5.
The Miracle of Tenecteplase: How This Drug Is Saving Lives
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation